Dr. Ferraro received a master’s degree in biology in 2012 and a PhD in Translational Medicine in 2016 from the Second University of Naples, Italy. In 2014, he joined Professor Oliver Soehnlein's laboratory at the Institute for Cardiovascular Prevention of the Ludwig Maximilian University of Munich, Germany, as a visiting doctoral student. After completing his PhD, he continued to work as a postdoctoral researcher in the same research group until February 2021. Since March 2021, he has been working as a postdoctoral researcher at the Institute of Cardiovascular Physiology and Pathophysiology at the Biomedical Centre of the Ludwig Maximilian University of Munich in the group of Dr. Ludwig Weckbach. His research focuses on studying the role of the innate immune system, with particular focus on monocytes/macrophages and neutrophils, in the onset of ischemic cardiac injury and experimental autoimmune myocarditis in rodents and humans. He also investigates how these cells orchestrate the resolution phase of these cardiac diseases.
Dr. Ferraro received a master’s degree in biology in 2012 and a PhD in Translational Medicine in 2016 from the Second University of Naples, Italy. In 2014, he joined Professor Oliver Soehnlein's laboratory at the Institute for Cardiovascular Prevention of the Ludwig Maximilian University of Munich, Germany, as a visiting doctoral student. After completing his PhD, he continued to work as a postdoctoral researcher in the same research group until February 2021. Since March 2021, he has been working as a postdoctoral researcher at the Institute of Cardiovascular Physiology and Pathophysiology at the Biomedical Centre of the Ludwig Maximilian University of Munich in the group of Dr. Ludwig Weckbach. His research focuses on studying the role of the innate immune system, with particular focus on monocytes/macrophages and neutrophils, in the onset of ischemic cardiac injury and experimental autoimmune myocarditis in rodents and humans. He also investigates how these cells orchestrate the resolution phase of these cardiac diseases.